Development of Theranostic Kit for Triple Negative Breast Cancer
Worldwide more than 1.5 million women annually are diagnosed with breast cancer. TNBC is the most aggressive subtype of breast cancer and has the worst prognosis.
Development of Early Diagnostic Kit for Mesothelioma
Mesothelioma is an aggressive tumour predominately caused by asbestos exposure. Prognosis of Malign Pleural Mesothelioma (MPM) patients is generally very bad, due to the fact that the disease is diagnosed only at later stages.
Development of Early Diagnostic Kit for Lung Cancer
Lung cancer is the main cause of death among cancer related mortalities. The main reasons for the high mortality rate are lack of early diagnosis and the lack of effective treatment.
Novel Method Development for Discovering Biomarkers for Early Cancer Diagnosis
Generally, protein arrays and SEREX are used to discover autoantibodies. Although many autoantibodies are identified by using these methods, these autoantibodies cannot be validated and used for cancer diagnosis clinically.